Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Clin Nutr ; 103(6): 1426-33, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-27030534

RESUMO

BACKGROUND: The consumption of advanced glycation end products (AGEs) has increased because of modern food processing and has been linked to the development of type 2 diabetes in rodents. OBJECTIVE: We determined whether changing dietary AGE intake could modulate insulin sensitivity and secretion in healthy, overweight individuals. DESIGN: We performed a double-blind, randomized, crossover trial of diets in 20 participants [6 women and 14 men; mean ± SD body mass index (in kg/m(2)): 29.8 ± 3.7]. Isoenergetic- and macronutrient-matched diets that were high or low in AGE content were alternately consumed for 2 wk and separated by a 4-wk washout period. At the beginning and end of each dietary period, a hyperinsulinemic-euglycemic clamp and an intravenous glucose tolerance test were performed. Dietary, plasma and urinary AGEs N(€)-(carboxymethyl)lysine (CML), N(€)-(carboxyethyl)lysin (CEL), and methylglyoxal-derived hydroimadazolidine (MG-H1) were measured with the use of mass spectrometry. RESULTS: Participants consumed less CML, CEL, and MG-H1 during the low-AGE dietary period than during the high-AGE period (all P < 0.05), which was confirmed by changes in urinary AGE excretion. There was an overall difference in insulin sensitivity of -2.1 mg · kg(-1) · min(-1) between diets (P = 0.001). Insulin sensitivity increased by 1.3 mg · kg(-1) · min(-1) after the low-AGE diet (P = 0.004), whereas it showed a tendency to decrease by 0.8 mg · kg(-1) · min(-1) after the high-AGE diet (P = 0.086). There was no difference in body weight or insulin secretion between diets (P = NS). CONCLUSIONS: A diet that is low in AGEs may reduce the risk of type 2 diabetes by increasing insulin sensitivity. Hence, a restriction in dietary AGE content may be an effective strategy to decrease diabetes and cardiovascular disease risks in overweight individuals. This trial was registered at clinicaltrials.gov as NCT00422253.


Assuntos
Dieta , Produtos Finais de Glicação Avançada/administração & dosagem , Resistência à Insulina/fisiologia , Sobrepeso/dietoterapia , Adulto , Glicemia/análise , Estudos Cross-Over , Método Duplo-Cego , Feminino , Técnica Clamp de Glucose , Teste de Tolerância a Glucose , Produtos Finais de Glicação Avançada/sangue , Produtos Finais de Glicação Avançada/urina , Humanos , Imidazolidinas/sangue , Imidazolidinas/urina , Insulina/sangue , Lisina/análogos & derivados , Lisina/sangue , Lisina/urina , Masculino , Pessoa de Meia-Idade , Aldeído Pirúvico/sangue , Aldeído Pirúvico/urina
2.
Amino Acids ; 46(2): 321-6, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23832534

RESUMO

It has been postulated that chronic exposure to high levels of advanced glycation end products (AGEs), in particular from dietary sources, can impair insulin secretion. In the present study, we investigated the cross-sectional relationship between AGEs and acute insulin secretion during an intravenous glucose tolerance test (IVGTT) and following a 75 g oral glucose tolerance test (OGTT) in healthy humans. We report the cross-sectional association between circulating AGE concentrations and insulin secretory function in healthy humans (17 F: 27 M, aged 30 ± 10 years) with a wide range of BMI (24.6-31.0 kg/m(2)). Higher circulating concentrations of AGEs were related to increased first phase insulin secretion during IVGTT (r = 0.43; p < 0.05) and lower 2-h glucose concentrations during OGTT (r = -0.31; p < 0.05). In addition, fasting (r = -0.36; p < 0.05) and 2-h glucose concentrations were negatively related to circulating levels of soluble receptor for AGE (RAGE) isoforms (r = -0.39; p < 0.01). In conclusion, in healthy humans, we show a cross-sectional association between advanced glycation end products and acute insulin secretion during glucose tolerance testing.


Assuntos
Produtos Finais de Glicação Avançada/sangue , Insulina/metabolismo , Adulto , Glicemia , Estudos Transversais , Feminino , Humanos , Insulina/sangue , Resistência à Insulina , Secreção de Insulina , Masculino , Receptor para Produtos Finais de Glicação Avançada , Receptores Imunológicos/sangue , Adulto Jovem
3.
Clin Chem Lab Med ; 52(1): 129-38, 2014 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-23525877

RESUMO

BACKGROUND: High levels of circulating advanced glycation end products (AGEs) can initiate chronic low-grade activation of the immune system (CLAIS) with each of these factors independently associated with cardiovascular (CV) morbidity and mortality. Therefore, our objective was to characterize the relationship between serum AGEs, CLAIS and other risk factors for CV disease in normotensive non-diabetic individuals. METHODS: We measured body mass index (BMI), waist-to-hip ratio (WHR), blood pressure, lipid and glucose profile in 44 non-diabetic volunteers (17 female, 27 males). Carboxymethyl-lysine (CML) was measured by ELISA as a marker for circulating AGEs and NF-κB p65 activity as an inflammatory marker by DNA-binding in peripheral blood mononuclear cells lysates (PBMC). RESULTS: Plasma CML concentrations were related to diastolic blood pressure (r=-0.51, p<0.01) independently of age, sex, BMI and WHR (p<0.05). Diastolic blood pressure was also related to NF-κB activity in PBMC (r=0.47, p<0.01) before and after adjustment for age, sex, BMI and WHR (p<0.05). Plasma CML concentrations were related to the pulse pressure before (r=0.42; p<0.05) and after adjustment for age, sex, BMI and waist (p<0.05). Neither CML nor NF-κB activity were related to systolic blood pressure (both p=ns). Plasma CML concentrations were not associated with plasma lipid or glucose concentrations (all p=ns). CONCLUSIONS: Plasma AGE levels and NF-κB activity in PBMC were independent determinants of diastolic and pulse pressure in healthy normotensive individuals. This association suggests a role for AGEs in the etiology of hypertension, possibly via the initiation of CLAIS and aortic stiffening.


Assuntos
Pressão Sanguínea/fisiologia , Produtos Finais de Glicação Avançada/sangue , Fator de Transcrição RelA/metabolismo , Adolescente , Adulto , Índice de Massa Corporal , Feminino , Humanos , Leucócitos Mononucleares/metabolismo , Lipídeos/sangue , Lisina/análogos & derivados , Lisina/sangue , Masculino , Pessoa de Meia-Idade , Relação Cintura-Quadril , Adulto Jovem
4.
Kidney Int ; 80(2): 190-8, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21412218

RESUMO

Obesity is highly prevalent in Western populations and is considered a risk factor for the development of renal impairment. Interventions that reduce the tissue burden of advanced glycation end-products (AGEs) have shown promise in stemming the progression of chronic disease. Here we tested if treatments that lower tissue AGE burden in patients and mice would improve obesity-related renal dysfunction. Overweight and obese individuals (body mass index (BMI) 26-39 kg/m(2)) were recruited to a randomized, crossover clinical trial involving 2 weeks each on a low- and a high-AGE-containing diet. Renal function and an inflammatory profile (monocyte chemoattractant protein-1 (MCP-1) and macrophage migration inhibitory factor (MIF)) were improved following the low-AGE diet. Mechanisms of advanced glycation-related renal damage were investigated in a mouse model of obesity using the AGE-lowering pharmaceutical, alagebrium, and mice in which the receptor for AGE (RAGE) was deleted. Obesity, resulting from a diet high in both fat and AGE, caused renal impairment; however, treatment of the RAGE knockout mice with alagebrium improved urinary albumin excretion, creatinine clearance, the inflammatory profile, and renal oxidative stress. Alagebrium treatment, however, resulted in decreased weight gain and improved glycemic control compared with wild-type mice on a high-fat Western diet. Thus, targeted reduction of the advanced glycation pathway improved renal function in obesity.


Assuntos
Produtos Finais de Glicação Avançada/efeitos adversos , Nefropatias/dietoterapia , Rim/fisiopatologia , Obesidade/dietoterapia , Obesidade/fisiopatologia , Receptores Imunológicos/efeitos dos fármacos , Adolescente , Adulto , Animais , Estudos Cross-Over , Dieta , Produtos Finais de Glicação Avançada/administração & dosagem , Humanos , Inflamação/prevenção & controle , Rim/efeitos dos fármacos , Nefropatias/induzido quimicamente , Nefropatias/tratamento farmacológico , Masculino , Camundongos , Camundongos Knockout , Pessoa de Meia-Idade , Obesidade/tratamento farmacológico , Receptor para Produtos Finais de Glicação Avançada , Receptores Imunológicos/deficiência , Tiazóis/farmacologia , Tiazóis/uso terapêutico , Adulto Jovem
5.
Diabetes ; 58(6): 1259-65, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19258436

RESUMO

OBJECTIVE: Chronic low-grade activation of the immune system (CLAIS) predicts type 2 diabetes via a decrease in insulin sensitivity. Our study investigated potential relationships between nuclear factor-kappaB (NF-kappaB) and c-Jun NH(2)-terminal kinase (JNK) pathways-two pathways proposed as the link between CLAIS and insulin resistance. RESEARCH DESIGN AND METHODS: Adiposity (dual-energy X-ray absorptiometry), waist-to-hip ratio (WHR), and insulin sensitivity (M, hyperinsulinemic-euglycemic clamp) were measured in 22 healthy nondiabetic volunteers (aged 29 +/- 11 years, body fat 28 +/- 11%). NF-kappaB activity (DNA-binding assay) and JNK1/2 activity (phosphorylated JNK) were assessed in biopsies of the vastus lateralis muscle and subcutaneous adipose tissue and in peripheral blood mononuclear cell (PBMC) lysates. RESULTS: NF-kappaB activities in PBMCs and muscle were positively associated with WHR after adjustment for age, sex, and percent body fat (both P < 0.05). NF-kappaB activity in PBMCs was inversely associated with M after adjustment for age, sex, percent body fat, and WHR (P = 0.02) and explained 16% of the variance of M. There were no significant relationships between NF-kappaB activity and M in muscle or adipose tissue (both NS). Adipose-derived JNK1/2 activity was not associated with obesity (all P> 0.1), although it was inversely related to M (r = -0.54, P < 0.05) and explained 29% of its variance. When both NF-kappaB and JNK1/2 were examined statistically, only JNK1/2 activity in adipose tissue was a significant determinant of insulin resistance (P = 0.02). CONCLUSIONS: JNK1/2 activity in adipose tissue but not NF-kappaB activity in PBMCs is an independent determinant of insulin resistance in healthy individuals.


Assuntos
Resistência à Insulina/fisiologia , Proteínas Quinases JNK Ativadas por Mitógeno/metabolismo , Leucócitos Mononucleares/enzimologia , NF-kappa B/metabolismo , Gordura Subcutânea/metabolismo , Adolescente , Adulto , Biópsia , Glicemia/metabolismo , Índice de Massa Corporal , Núcleo Celular , Primers do DNA , Feminino , Humanos , Proteínas Quinases JNK Ativadas por Mitógeno/genética , Contagem de Leucócitos , Masculino , Pessoa de Meia-Idade , Proteína Quinase 8 Ativada por Mitógeno/genética , Proteína Quinase 8 Ativada por Mitógeno/metabolismo , Proteína Quinase 9 Ativada por Mitógeno/genética , Proteína Quinase 9 Ativada por Mitógeno/metabolismo , Músculo Esquelético/citologia , Músculo Esquelético/metabolismo , Valores de Referência , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Relação Cintura-Quadril , Adulto Jovem , eIF-2 Quinase/genética , eIF-2 Quinase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...